Intravascular Ultrasound (IVUS): A Global Strategic Business Report
San Jose, California (PRWEB) November 06, 2013
Follow us on LinkedIn - Since its introduction in the 1990s, intravascular ultrasound (IVUS) dramatically widened the horizons of invasive coronary intervention and emerged as a critical adjunctive imaging tool for coronary angiography. IVUS is fast becoming a benchmark for atherosclerosis imaging, enabling highly sensitized detection of stenosis, and accurate characterization and quantitative assessment of plaque, besides optimizing stenting procedures. The fast growing aging global populace, and the rising incidence and prevalence of cardiovascular diseases continues to drive the demand for Percutaneous Coronary Intervention (PCI) procedures, which in turn is propelling the use of IVUS. IVUS is therefore emerging as one of the fastest growing segments in the world ultrasound imaging systems market.
Affordability, technological refinements, and user-friendliness of IVUS systems are paving way for increased adoption of the technology. One of the major factors nurturing growth is the emergence of robust data from large scale clinical trials such as PROSPECT and ADAPT-DES supporting the use of IVUS as an adjuvant tool in stenting and angiography procedures. Positive results from the recent ADAPT-DES IVUS substudy will additionally support the elevation of IVUS to class Ia category medical devices, besides encouraging physician adoption of the same. Strong product pipeline of IVUS vendors is another factor fuelling growth in the market, with 3D IVUS reconstruction software, cMUT transducers FL.IVUS and FL.ICE catheters being the new technologies that are expected to make waves in the near term.
Although IVUS has established itself as a reliable technology among interventional cardiologists worldwide, its current low penetration level provides significant untapped potential for growth. With the exception of Japan, penetration levels of IVUS in PCI procedures remain in the range of low-single to low-double digit rates. The lack of a flexible reimbursement structure similar to the Japanese model, coupled with the lack of adequate training, are factors inhibiting growth in the US, Europe and other major geographic markets. Although, IVUS is facing tough competition from alternative techniques such as Fractional Flow Reserve (FFR) and Optical Coherence Tomography (OCT), neither of the three technologies have been established as the standard-of-care for intravascular intervention, thereby providing ample scope for the promotion of multimodality systems in the near term.
As stated by the new market research report on Intravascular Ultrasound (IVUS), Japan represents the largest market worldwide supported by favorable domestic reimbursement structure and relatively high number of PCI and complex surgical procedures performed in the country. Buoyed by favorable macroeconomic and demographic factors, emerging economies are expected to spearhead growth with Asia-Pacific forecast to display the fastest CAGR of 13.9% over the analysis period. Among the two product segments, IVUS Catheters remains the key revenue-generating market for IVUS device manufacturers.
Major players covered in the report include Volcano Corporation, Boston Scientific Corporation, Terumo Corporation, InfraReDx Inc., and Silicon Valley Medical Instruments Inc.
The research report titled “Intravascular Ultrasound (IVUS): A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides an in-depth review of market trends, drivers, issues, mergers, acquisitions and other strategic corporate activities of major companies worldwide. The report provides market estimates and projections for all major geographic markets such as the US, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia and Rest of Europe), Asia-Pacific (China, India, and Rest of Asia-Pacific), and Rest of World. Product markets analyzed in the report include IVUS Catheters and IVUS Consoles.
For more details about this comprehensive market research report, please visit http://www.strategyr.com/Intravascular_Ultrasound_IVUS_Market_Report.asp.
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.
Global Industry Analysts, Inc.
Telephone: 408-528-9966
Fax: 408-528-9977
Email: press(at)StrategyR(dot)com
Web Site: http://www.StrategyR.com
